recombinant botulinum toxin targeted secretion inhibitors (Ipsen/Ipsen Bioinnovation)

N/A

Report date: 2025/03/20 09:38:29

Base Information

Drug Namerecombinant botulinum toxin targeted secretion inhibitors (Ipsen/Ipsen Bioinnovation)
Drug Alias Namerecombinant botulinum toxin (Ipsen/Syntaxin)recombinant botulinum toxin targeted secretion inhibitors (Ipsen/Syntaxin)
ClassificationBiologics > Protein drugs > ToxinBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionMuscarinic acetylcholine receptor antagonists
TargetsMuscarinic acetylcholine receptor
Therapy Area/IndicationsEndocrine System DiseasesNervous System DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited KingdomFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIpsen BioInnovation Ltd
China Registration ClassN/A

Develop Information

Active CompaniesIpsen BioInnovation LtdIpsen SA
Inactive CompaniesN/A
Active IndicationsEndocrine System DiseasesNervous System DiseasesNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A